Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer.
Einefors, Rickard ; Kogler, Ulrika ; Ellberg, Carolina LU
and Olsson, Håkan
LU
(2013)
In SpringerPlus
2.
- Abstract
- Breast cancer (BC) is one of the leading causes of death among women worldwide. Immunostimulatory treatment has increasingly been used as adjuvant therapy in the last few years, in patients with melanoma and other cancer forms, often with an induction of autoimmunity as a consequence of a successful treatment. We aimed at investigating if coexisting autoimmune diseases (AD) or hypersensitivities (HS) similarly to the side effects of immunostimulatory treatment resulted in a better overall survival, compared to patients without these disorders.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4066218
- author
- Einefors, Rickard
; Kogler, Ulrika
; Ellberg, Carolina
LU
and Olsson, Håkan
LU
- organization
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- subject
- in
- SpringerPlus
- volume
- 2
- article number
- 357
- publisher
- Springer
- external identifiers
-
- pmid:24010029
- pmid:24010029
- wos:000209465000155
- scopus:84887292491
- ISSN
- 2193-1801
- DOI
- 10.1186/2193-1801-2-357
- language
- English
- LU publication?
- yes
- id
- ae3cda1a-61a4-4f9d-ad53-487ba69d8744 (old id 4066218)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/24010029?dopt=Abstract
- date added to LUP
- 2016-04-01 14:09:04
- date last changed
- 2022-03-29 19:23:48
@article{ae3cda1a-61a4-4f9d-ad53-487ba69d8744,
abstract = {{Breast cancer (BC) is one of the leading causes of death among women worldwide. Immunostimulatory treatment has increasingly been used as adjuvant therapy in the last few years, in patients with melanoma and other cancer forms, often with an induction of autoimmunity as a consequence of a successful treatment. We aimed at investigating if coexisting autoimmune diseases (AD) or hypersensitivities (HS) similarly to the side effects of immunostimulatory treatment resulted in a better overall survival, compared to patients without these disorders.}},
author = {{Einefors, Rickard and Kogler, Ulrika and Ellberg, Carolina and Olsson, Håkan}},
issn = {{2193-1801}},
language = {{eng}},
publisher = {{Springer}},
series = {{SpringerPlus}},
title = {{Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer.}},
url = {{https://lup.lub.lu.se/search/files/3816726/4317760.pdf}},
doi = {{10.1186/2193-1801-2-357}},
volume = {{2}},
year = {{2013}},
}